These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 10623654)

  • 41. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
    Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capturing circulating tumor cells of hepatocellular carcinoma.
    Wu LJ; Pan YD; Pei XY; Chen H; Nguyen S; Kashyap A; Liu J; Wu J
    Cancer Lett; 2012 Dec; 326(1):17-22. PubMed ID: 22842097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.
    Zabaglo L; Ormerod MG; Parton M; Ring A; Smith IE; Dowsett M
    Cytometry A; 2003 Oct; 55(2):102-8. PubMed ID: 14505315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
    Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
    Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.
    Chinen LT; Mello CA; Abdallah EA; Ocea LM; Buim ME; Breve NM; Gasparini JL; Fanelli MF; Paterlini-Bréchot P
    Onco Targets Ther; 2014; 7():1609-17. PubMed ID: 25258541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
    Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
    Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
    Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
    Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative Enrichment and Isolation of Circulating Tumor Cells for Whole Genome Amplification.
    Kanwar N; Done SJ
    Methods Mol Biol; 2017; 1634():143-152. PubMed ID: 28819847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.
    Ilie M; Hofman V; Leroy S; Cohen C; Heeke S; Cattet F; Bence C; Lalvée S; Mouroux J; Marquette CH; Hofman P;
    Clin Chem Lab Med; 2018 May; 56(6):980-989. PubMed ID: 29397019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    Castle J; Morris K; Pritchard S; Kirwan CC
    PLoS One; 2017; 12(4):e0175647. PubMed ID: 28422972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. All-in-one centrifugal microfluidic device for size-selective circulating tumor cell isolation with high purity.
    Lee A; Park J; Lim M; Sunkara V; Kim SY; Kim GH; Kim MH; Cho YK
    Anal Chem; 2014 Nov; 86(22):11349-56. PubMed ID: 25317565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
    Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
    Jia M; Mao Y; Wu C; Wang S; Zhang H
    Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors.
    Nastały P; Honecker F; Pantel K; Riethdorf S
    Methods Mol Biol; 2021; 2195():245-261. PubMed ID: 32852768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of circulating tumor cells in blood by shell-isolated nanoparticle - enhanced Raman spectroscopy (SHINERS) in microfluidic device.
    Niciński K; Krajczewski J; Kudelski A; Witkowska E; Trzcińska-Danielewicz J; Girstun A; Kamińska A
    Sci Rep; 2019 Jun; 9(1):9267. PubMed ID: 31239487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokeratin-based CTC counting unrelated to clinical follow up.
    Chinen LT; de Carvalho FM; Rocha BM; Aguiar CM; Abdallah EA; Campanha D; Mingues NB; de Oliveira TB; Maciel MS; Cervantes GM; Dettino AL; Soares FA; Paterlini-Bréchot P; Fanelli MF
    J Thorac Dis; 2013 Oct; 5(5):593-9. PubMed ID: 24255771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.
    Wang Z; Luo L; Cheng Y; He G; Peng B; Gao Y; Jiang ZS; Pan M
    J Gastrointest Surg; 2018 Apr; 22(4):633-639. PubMed ID: 29159757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.